BACKGROUND: As the main component of cordycepic acid, corbrin capsule mainly functions to improve blood lipids and protect the kidneys. Human amniotic mesenchymal stem cells are a kind of stem cells that have stronger differentiation potential than bone marrow mesenchymal stem cells. However, there are less reports on renal injury repair and post-repair functional improvement.
OBJECTIVE: To observe the effect of human amniotic mesenchymal stem cell transplantation with corbrin capsule on blood coagulation and renal functions of rats with nephrotic syndrome.
METHODS: Human amniotic mesenchymal stem cells were cultured in vitro and made into cell suspension labeled with with CM-Dil. Fifty Sprague-Dawley were randomly divided into five groups (n=10 per group): normal control group with no intervention, model group, cell transplantation group, corbrin capsule group and combined treatment group. Except the normal control groups, rats in all the groups were used to make nephropathy models by rats by intravenous injection of adriamycin. After modeling, rats in the latter three groups were given intravenous injection of human amniotic mesenchymal stem cells for 3 days, intragastric administration of corbrin capsule for 12 weeks, and the combination of cell transplantation and corbrin capsule, respectively. Twelve weeks later, serum creatinine, blood urea nitrogen, blood coagulation index, and 24-hour urine protein levels were detected. Pathological changes of the renal tissues were observed by hematoxylin-eosin staining. Survival and distribution of CM-Dil labeled human amniotic mesenchymal stem cells were observed by fluorescence microscope. Apoptosis in renal tissues was detected using TUNEL method.
RESULTS AND CONCLUSION: Serum creatinine, blood urea nitrogen and 24-hour urine protein levels in the cell transplantation and corbrin capsule groups were significantly decreased compared with the model group, but still higher than that in the combined treatment group (P < 0.05). Coagulation indexes in the combined treatment group were significantly lower than those in the cell transplantation and corbrin capsule groups (P < 0.05). The hypercoagulable state of rats was relieved in the three treatment groups. Pathological changes of the renal tissues were deteriorated in the model group, and improved in the three treatment groups, especially in the combined treatment group. Under the florescence microscope, the number of CM-Dil-labeled human amniotic mesenchymal stem cells was higher in the combined treatment group than the cell transplantation and corbrin capsule groups. Compared with the model group, the cell apoptosis in the renal tissue was relieved in the three treatment groups, especially in the combined treatment (P < 0.05). To conclude, human amniotic mesenchymal stem cell transplantation with corbrin capsule can improve renal function and hypercoagulable state of nephrotic syndrome rats, by reducing the degree of proteinuria, improving the degree of pathological damage and reducing renal cell apoptosis.
中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程